Clinical Trials - June 8, 2015
Novo Drug Works During Ramadan Fast
Adults with type 2 diabetes treated with Novo Nordisk’s Victoza®, in combination with metformin, experienced similar improvements in blood glucose control while fasting during the four weeks of Ramadan compared with sulfonylurea (SU) plus metformin, according to a recent study. People treated with Victoza® also demonstrated greater weight loss and fewer confirmed hypoglycemic episodes compared with […]